MONTI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 177
AS - Asia 96
EU - Europa 43
SA - Sud America 21
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 341
Nazione #
US - Stati Uniti d'America 169
SG - Singapore 49
CN - Cina 18
BR - Brasile 17
HK - Hong Kong 14
RU - Federazione Russa 11
SE - Svezia 9
GB - Regno Unito 8
FI - Finlandia 4
AR - Argentina 3
CA - Canada 3
MX - Messico 3
PK - Pakistan 3
TR - Turchia 3
DE - Germania 2
ID - Indonesia 2
IQ - Iraq 2
IT - Italia 2
LT - Lituania 2
NL - Olanda 2
PL - Polonia 2
VN - Vietnam 2
BD - Bangladesh 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
IE - Irlanda 1
JP - Giappone 1
LY - Libia 1
NI - Nicaragua 1
PA - Panama 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 341
Città #
Ashburn 35
Singapore 19
Woodbridge 16
Chandler 15
Hong Kong 14
Fairfield 9
Beijing 8
Houston 8
Los Angeles 8
Nyköping 7
Seattle 7
Wilmington 7
Cambridge 5
Poplar 5
Brooklyn 4
São Paulo 4
Hefei 3
Helsinki 3
Jacksonville 3
Ann Arbor 2
Augusta 2
Dearborn 2
Denver 2
Ho Chi Minh City 2
Jakarta 2
Santa Clara 2
Toronto 2
Adapazarı 1
Amsterdam 1
Avaré 1
Baghdad 1
Belo Horizonte 1
Boardman 1
Buffalo 1
Cairo 1
Charleston 1
Córdoba 1
Dallas 1
Des Moines 1
Diadema 1
Dublin 1
Erbil 1
Falkenstein 1
Franca 1
Honolulu 1
Islamabad 1
Istanbul 1
Itamaraju 1
Itanhaém 1
Kansas City 1
Lahore 1
Lawrence 1
Leawood 1
Lodz 1
London 1
Managua 1
Manhumirim 1
Mar del Tuyú 1
Mauá 1
Mexico City 1
Montreal 1
Mount Laurel 1
Munich 1
Nanjing 1
New York 1
Orlando 1
Panama City 1
Perdões 1
Pescara 1
Princeton 1
Ribeirão Branco 1
Riyadh 1
Roxbury 1
San José Iturbide 1
San Miguel de Tucumán 1
Shenyang 1
Suffern 1
São José 1
São Sebastião do Paraíso 1
Tianjin 1
Tokyo 1
Tripoli 1
Tunis 1
Tuxtla Gutiérrez 1
Villarrica 1
Warsaw 1
Xanxerê 1
Zutphen 1
Totale 257
Nome #
Validation of the classification criteria for cryoglobulinaemic vasculitis 145
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 72
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 49
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 48
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 45
Totale 359
Categoria #
all - tutte 1.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 3 0 3 2 1
2021/202216 2 0 0 1 1 2 0 2 0 2 3 3
2022/202332 3 6 2 2 5 2 0 4 6 0 2 0
2023/20248 0 1 0 3 0 0 0 0 1 2 0 1
2024/2025102 3 0 7 0 0 11 21 16 3 4 8 29
2025/2026124 37 9 14 19 37 8 0 0 0 0 0 0
Totale 359